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Summary 
Idiotype (Id) 16/6 marks a variable (V) region structure that occurs frequently in the human 
immunoglobulin repertoire.  The basis of the Id has been traced to a germline heavy chain gene 
segment, V.18/2 (V.26). To pursue the molecular basis for the frequency of Id 16/6, we have 
analyzed polymerase chain reaction-generated C/z, C% and V.3 family V gene libraries derived 
from the circulating and tonsillar B cells of four normal individuals and from the B cells of 
two patients with active systemic lupus erythematosus (SLE). The frequency of V.18/2 in these 
libraries was compared with three control V. genes, V.56P1, V.21/28, and V.A57. Plaque lifts 
from C/z and C3' V. cDNA libraries were screened with gene-specific oligonucleotide probes. 
The frequency of V.18/2 ranged from 4 to 10% ofJ. + plaques (two to five times that of control 
V.  genes).  In  four  V.3  family-specific  libraries  derived  from  rearranged  DNA,  V.18/2 
represented  19-33% of V.3 + plaques. Hybridizing V.18/2 plaques were 98-100% homologous 
to  the  germline V.  gene;  mutations when present  were often in  framework 3.  Extensive 
variation was seen in the complementarity determining region 3 sequences of these rearranged 
V genes. The high frequency of V.18/2 expression  in the B cell repertoire was confirmed by 
sequencing randomly picked J.+  plaques. In two patients with active SLE the frequency of use 
of V.18/2 was  not greater than that observed in normal subjects.  These results show that 
V.18/2  is  overrepresented in  the B  cell repertoire of normal subjects  and  suggest that  the 
immune repertoire may be dominated by relatively  few V  genes. 
I 
d 16/6, an idiotypic marker identified originally in a human 
IgM anti-DNA mAb, has been found in the serum of most 
patients with active SLE, in the renal and skin lesion of lupus, 
in the serum of patients with certain bacterial infections or 
autoimmune diseases other than SLE, in 10% of monoclonal 
gammopathies, and in normal serum. The Id occurs in a wide 
spectrum of racial and ethnic groups, and B cells from cord 
blood, children, and adults can all produce it (reviewed in 
reference 1). Id 16/6 thus marks a V region structure that 
occurs in high frequency in the human Ig repertoire.  The 
basis of the Id has been traced to a germline heavy chain gene 
segment, V.18/2 (also called V.26 and V.30p1), a member 
of the V.3 family (2). V.18/2 has been localized to a 500- 
kb region in the 3' end of the V. locus (3). The germline 
gene has a unique defining sequence in the 5' region of its 
CDR2,  and  an  oligonucleotide probe  corresponding  to 
this region was shown to hybridize to a single 2.0-kb band 
in genomic DNA (4). This probe has identified V.18/2 in 
the genomic DNA of >98% of tested subjects.  Moreover, 
all genomic clones identified by moderate stringency hybrid- 
ization with the CDR2 probe had an identical sequence (5). 
V.18/2  is  thus highly conserved and its  Ig product is 
found in a variety of normal and pathological conditions. To 
test the possibility that V.18/2 is overrepresented in B cell 
populations, we studied the frequency of this gene in the ex- 
pressed V. gene repertoire of two normal individuals.  To 
survey the expressed human V. gene repertoire, we gener- 
ated Ig cDNA libraries from B cells obtained from normal 
adults in a two-step PCR procedure without B cell selection 
or manipulation. V gene primers are not used in this proce- 
dure, thus allowing random amplification of all V. families 
(6).  The frequency of V.18/2 use was  also determined in 
V.3 family-specific libraries generated by the PCR of rear- 
ranged Ig DNA from the peripheral blood of a normal adult, 
a tonsil, and from the blood of two patients with SLE. The 
frequency of V.18/2 in these libraries was determined by hy- 
bridization to plaque lifts with the gene-specific probe and 
confirmed by sequence  analysis. The results  with V.18/2 
were compared with two other V.3 family genes,  V.56p1 
and  V.A57,  and  with  V.21/28  (a  member of the  V.1 
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B cells that had rearranged V.18/2, and suggest that the V. 
gene repertoire of human  B cells is strongly biased. 
Materials  and Methods 
Ig eDNA  Libraries.  PBMC isolated from  two normal  adult 
donors (Caucasian and Asian) by centrifugation  through  Ficoll- 
Hypaque were washed twice in PBS. No further manipulation was 
carried out before extraction of mRNA over an oligo(DT) column 
(Invitrogen, San Diego, CA). Double-stranded (ds)cDNA was syn- 
thesized from  mRNA according to the method of Gubler  and 
Hoffman  (7) and blunt ended with T4 DNA polymerase. The 
primer for cDNA synthesis was complementary to a sequence  within 
the C/~1 or C3'1 regions. Two steps of PCR amplification were 
performed, as described previously (6). The first step was primed 
by oligonucleotide primers attached to the ends of the ds cDNA. 
The products were ligated into M13mp19 replicative (RF) DNA. 
A second amplification used a downstream nested C/x primer and 
an upstream primer within the M13 vector DNA. The second PCR 
products were again ligated to M13RF DNA. This ligation mix- 
ture was transformed into DH5c~ bacteria to form the cDNA li- 
brary for screening. The M13 plaques were lifted onto Genescreen 
membranes (DuPont-New England Nuclear, Boston, MA), and the 
membranes were prehybridized, hybridized,  and washed at high 
stringency as described by Treppichio and Barrett (8). Radiolabeled 
probes were stripped from the membranes before rehybridization. 
Plaque lifts were screened by hybridization to a degenerate J. gene 
oligonucleotide probe. The J. probe was end-labehd by T4 poly- 
nucleotide kinase and 3,-[32P] according to Manniatis et al.  (9). 
Oligonucleotide  probes (Fig. 1) complementary  to the conserved 
framework 3 (Fr3)  1 regions of the V.1 and V.3 families and to the 
CDK  regions  of the  individual  V.  genes (V.18/2,  V.21/28, 
V.56pl, and V.A57) were synthesized (Oligos etc. Inc., Wilson- 
ville, OR), and these overlapping oligonucleotides were labeled by 
filling in of the ends with the Klenow fragment  of DNA poly- 
merase 1 and c~-[nP]deoxynucleoside triphosphates.  Unincorpo- 
rated nucleotides were removed on NENSORB columns (DuPont- 
New England  Nuclear).  For more detailed analysis hybridizing 
plaques were picked for sequencing by chain termination  with 
dideoxynucleoside triphosphates and sequenase (U.S. Biochemical 
Co., Cleveland, OH). The resulting sequences were compared with 
published  sequences in the human  GenBank database with the 
FASTA program  of the GCG software package (10). 
I,',3 Family-specific Libraries.  DNA was extracted from lym- 
phoid cells by proteolysis, phenol/chloroform extraction, and precipi- 
tated in ethanol.  PCR amplification was carried out using a V.3 
leader sequence primer (GCTCTAGAACCATGGAGTTTGGGC- 
TGAG) and a consensus J. primer (GGGAATTCTGAGGAGACG- 
GTGACCAGGGT).  The primers contained XbaI and EcoRI re- 
striction  sites to facilitate cloning. The conditions were a 5-min 
denaturation  at 98~  followed by 94~  for 1 rain, 55~  for 1.5 
rain, and 72~  for 1.5 min for 40 cycles with a 10-min extension 
at 72~  to finish. The resulting band was cut from low melting- 
temperature agarose gel. Transformation into DHScff' Escherichia 
coli was performed, and plaque lifts were screened as described above. 
Results 
Specificity  of Oligonucleotide  Probes.  The frequency of hy- 
bridization of V,18/2 and control probes was determined in 
1 Abbreviation used in this paper: Fr3, framework 3. 
VH3 
(FW3) 
VHI 
(FW3) 
VHI8/2 
(5'cdr2) 
VHA57 
(5'cdr2; 
VH56pl 
(5'cdr2) 
VH21/28 
(cdrl) 
5'CTCCAGAGACAATTCCAAGAACACGCTGTA  3' 
3'GTTCTTGTGCGACATAGACGTTTACTTGTC  5' 
5'  GACCAGGGACACGTCCATCAGCACAGCCTA  3' 
3'  TAGTCGTGTCGGATGTACCTCGACTCGTCC  5' 
5'  GCTATTAGTGGTAGTGGT  3' 
3'  TCACCATCACCACCATCG  5' 
5'  GTTATTTATATCGGTGGT 
3'  TATAGCCACCATGGGGTA  5' 
5'  GTTATATCATATGATGGA  3' 
3'  GTATACTACCTTCGTTAT  5' 
5'  GCGCACCCAATGCATAGCATAGCT  3' 
3'TACGTATCGTATCGATCACTTCCA  5' 
VH21/28  5'  GAACTTCTGTGAAT  3' 
(cdr2)  3 ' GACACTTATAAAACAT  ~  ' 
Figure  1.  Oligonucleotide  probes used to screen libraries. Labeling  was 
performed using a fill-in reaction. 
the PCtL-generated  Ig-specific libraries.  Controls included: 
V.56pl,  a VH3 family member found initially in fetal liver 
B cells (11); V.21/28,  a germline V.1 family member found 
in autoantibodies  (12);  and V.A57,  which is most likely a 
somatically mutated variant  of V,18/2  (4).  The  specificity 
of the oligonucleotide probes for the V.18/2  and V.21/28 
gene segments has been demonstrated previously (4). These 
experiments  showed  that  an  oligonucleotide  probe  com- 
plementary to the 5' end of the CDR2 of V.18/2  hybrid- 
ized to a single 2.0-kb band on a Southern blot of digested 
genomic DNA. Sequence analysis has confirmed that hybrid- 
ization identifies a single germline V. gene (4). The present 
experiments confirmed the specificity of the V,18/2 probe, 
which  at  high  stringency  identified  only  plaques  with 
97-100%  homology to V~18/2 (see below). Hybridization 
with a combination of probes, identifying both the CDR1 
and CDR2 of V.21/28,  had a similar  high  specificity (D. 
R.ubinstein, unpublished data).  The oligonucleotide probes 
for  V.56p1  and  VHA57  were  complementary  to  their  5' 
CDR2 regions. Our V. oligonucleotide overlapped two pre- 
viously described oligonucleotide probes, M10 (13) and H61 
(14). At high stringency both M10 and H61 identify the two 
bands  on  TaqI-digested  DNA  that  contain  the  V.56pl 
germline gene (hv3005) and the highly related GLSJ2 germ- 
line gene (13, 14). This area also shares identity with the closely 
related yet independent germline gene V.1.9III (13). In fact, 
in our hands,  the V.56pl  oligonucleotide probe, when hy- 
bridized at moderate stringency (10~  below the Tm) to a 
Southern blot of PstI-digested granulocyte DNA from normal 
donors, revealed three bands of 35, 15, and 5.2 kb. (not shown). 
The  lack  of specificity  of the  V.56pl  oligonucleotide  is 
therefore likely to overestimate the frequency of expression 
of this gene; furthermore, the use of high-stringency washes 
may underestimate the frequency of expression of V.18/2 by 
excluding expressed V. genes that  have undergone somatic 
mutation  in the region  identified by the oligonucleotide. 
V,  dS/2  Is Expressed at High  Frequency  in Normal Adults. 
IgM cDNA libraries were generated from the PBL of two 
normal individuals  (A/z, T/z) (15). The resultant library plaque 
lifts  were  screened  with  a  consensus JR probe,  conserved 
family-specific  VH3 and V.1 probes, and, at high stringency, 
410  V. Repertoire of Human B Cells Table  1.  Frequency of Oligonucleotide Hybridization to C/z and C  7  Libraries  from  Two Individuals 
Name  J,  V.3  18/2  56P1  A57  V.1  21/28 
%  %  %  %  % 
A/~  468  134 (29)  45  (10)  -  -  140 (35)  - 
A/z.B  344  129 (37)  34  (10)  11  (3)  0  142 (41)  8 (2) 
A3'  1,012  631  (61)  45  (4)  9  (1)  0  -  - 
A#2  432  149 (34)  33  (8)  .... 
T~  284  114 (40)  14 (5)  7 (2)  0  83  (29)  6  (4) 
Libraries  A/~ and  A#2  were from  the  same individual  after  a  1-yr interval.  A/~.B and  A3' are from  the same  starting  mlLNA  sample  as A/~. 
with the V818/2-,  V.21/28-,  Va56pl-,  and V.A57-specific 
oligonucleotides. Differences between the two individuals were 
noted (Table  1); the V.18/2 probe hybridized to 10% ofJ. + 
plaques in A/~ but only to 5% of plaques in T/~ (Fig. 2) (33 
and 12% of all V.3 + plaques, respectively). By comparison, 
in both  subjects only 2%  of all J.+  plaques hybridized to 
the V,56p1  or VH21/28 probes.  The V.A57 probe did not 
hybridize to any plaques from either individual.  The high 
frequency of expression of V.18/2 in A/~ was confirmed in 
a  duplicate  IgM library  generated from  the  same  starting 
mRNA sample (A/~.B), in which 10%  of J. + plaques also 
hybridized  to  the  V.18/2  probe.  Although  the  predomi- 
hence of the VH1 family persisted in this duplicate library 
and  the  frequency  of V.18/2  remained  constant,  the  fre- 
quency of V.3  hybridizing  plaques  was  higher  in  library 
A/~.B ~  < 0.01). Sequencing analysis of 54 randomly picked 
plaques from both A/~ and A#.B demonstrated that 26 and 
29%  of clones in the respective libraries belong to the V.3 
family. This finding strongly suggests that the observed differ- 
ences in V. family distribution reflect variations in hybrid- 
ization conditions rather than a PCR-induced amplification 
bias.  2  of 23 clones,  in which full V. sequences were ob- 
tained, shared 99.7% identity with V.18/2.  A third library 
(A/~2) was generated from this same individual after an in- 
terval of 11 mo. On this occasion, 8% of plaques hybridized 
to  the V.18/2  probe,  demonstrating  stability  of the over- 
representation with  time. 
Sequences of randomly picked plaques from these libraries 
demonstrated that each had a distinct CDR3 sequence, ruling 
out  clone  duplication  secondary  to  PCR.  12  VH18/2  hy- 
bridizing plaques from these C/~ libraries were sequenced at 
least through CDR,1 (three from A/z, eight from A/~.B, and 
one from T/~) (Fig. 3). All sequences have an open reading 
frame (Fig. 4). Little mutation was found in the V. regions. 
Three sequenced clones from A# (ALl.l, ALl.2, ALl.3) had 
1,  10,  and 3  mutations in Fr3  and one silent  mutation in 
CDR2.  In contrast, in the library obtained 1 yr later (A/~2), 
only two of eight clones had any mutation and on this occa- 
sion all three mutations occurred in the CDRs.  The single 
sequenced clone from T/~ had five mutations,  four in Fr3, 
and one in  CDR2. 
Although  V.18/2  is  highly conserved in  the  germline, 
JH  Posilive  (400)  VH3  (92)  18/2  (16) 
Figure 2.  Plaque lifts from T# were hybridized sequentially to J., V.3, and V.18/2 probes. On this representative lift V.3 + plaques represent 23% 
of all Jr +  plaques;  V.18/2  hybridized  to  17%  of V.3 +  and  to 4%  ofJH +  plaques. 
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ALI.I 
ALI.2 
ALI.3 
TKI 
AL3.1 
AL3.2 
AL3.4 
AL3.5 
AL3.7 
AL3.10 
AL3.11 
AL3.16 
I  SO 
GAGGTGCA•CTGTTG•AGTCTGGGGGAGG•TT•GTACAG•CTGGGG•GTCC•TGAGACTCTCCTGTGCAGCCTCTG•TT•ACCTTTAGCAGCTATGCC 
................................................  A  ....... 
ALI.I 
ALI.2 
ALI.3 
TKI 
AL3.1 
AL3.2 
AL3.4 
AL3.5 
AL3.7 
AL3.10  .................................................................................................. 
AL3.11  .................................................................................................. 
AL3.16  .................................................................................................. 
I00  150 
ATGAGCTGGGT~CGcCAGCGT~CAGGGAAGGGGCTGGAGTGGGTCTCAGcTATTAGTG~TAGTGGTGGTAGCACATACTACGCAGACTCCC~TGAAGGC~ 
.................................................................................................. 
.................................................................................................. 
..................................................  C  ............................................... 
.......................................................................  T  .......................... 
.................................................................................................. 
.................................................................................................. 
.................................................................................................. 
.................................................  G  ...........................  T  .................... 
.................................................................................................. 
200  250 
CCGGTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCC•GAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAA 
ALI.I  ......................................................................................  T  .......... 
ALI.2  ....... G  ..............  G  .......................................  A-A  ..........  A  .....  G ........ CA-C-C- 
ALI.3  ......................................................  GGC  ........................................ 
TKI  ..................................  T-A  .........................................  T--G  .............  G- 
AL3.1  ................................................................................................ 
AL3.2  ................................................................................................. 
AL3.4  ................................................................................................. 
AL3.5  .......................................................................... 
AL3.7  .............................................................................................. 
AL3.10  ................................................................................................. 
AL3.11  ................................................................................................. 
AL3.16  ................................................................................................. 
Figure  3.  Nucleotide sequences 
of 12 VH18/2  hybridizing plaques 
are compared with the germline se- 
quence  V.26.  The  CDR1  and 
CDR2  regions  are  underlined. 
These  sequence  data are  available 
from EMBL/GenBank/DDBJ  un- 
der  accession  numbers  X67060- 
X67071. 
not all members of the V.3 family have been identified and 
we were thus unable to conclude  definitively that the ob- 
served variations from  V.18/2  are indeed due  to  somatic 
mutation. Therefore, PCR primers spanning regions of mu- 
tation in clones ALl.2 and ALl.3 were used to amplify non- 
lymphoid DNA. The absence of an amplifiable product sup- 
ported the probability that the observed base differences were 
acquired by somatic mutation (not shown). 14 of 23 muta- 
tions documented  in all 12 sequenced VH18/2 clones (A#, 
A/z2, T/~) resulted in amino acid substitutions, a replacement- 
1812 
ALl 
AL2 
AL3 
TKI 
AL3  1 
AL3  2 
AL3  4 
AL3  5 
AL3  7 
AL3  I0 
AL3  ii 
AL3  16 
18/2 
ALI.I 
ALI.2 
ALI.3 
TKI 
AL3.1 
AL3.2 
AL3.4 
AL3.5 
AL3.7 
AL3.10 
AL3.11 
AL3.16 
CDRI  CDR2 
EVQLLESGGGLVQPGGSLRLSCAASGFTFS  SYAMS  WVRQAPGKGLEWVS  AISGSGGSTYYADSVKG 
............................................................... 
............................................................... 
.................................................................. 
................................................................ 
..................................................... 
................  N ................................... 
........................................................ 
.................................................  S ................ 
............................................................ 
...................................................... 
.............................................................. 
................................................... 
CDR3 
RFTISRDNSKNTLYLQMNSLRAEDTAVYYCA 
............................  F--  KDIVLVVYAGDDA  FDI  W 
--A  ....  D ............  KT ........  T  TDIASCYKSYCAM  DV  W 
.................  KA ............  KDKAYYDTPI  DY  W 
...........  S ...................  RDPVHSWANW  FDP  W 
...............................  KDRAKTPNDYGDYFPTY  YFDY  W 
...............................  KLSADSGYDSGE  YFDY  W 
...............................  KDPSPYSNSVGR  FDY  W 
............................... 
...............................  RIPPADGRY  YFDY  W 
...............................  KDTREEDFWSGYYNYYGM  DV  W 
...............................  KGP  YFD  W 
...............................  KCSELR  YFD  W 
Figure  4.  Predicted amino acid 
sequences of 12 sequenced V.18/2 
hybridizing plaques. 
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CLONE  N  D  N  JH 
ALl. i  GATATTGTAcTGGTGGTgt  aTGC  GGGGGATGAT 
DLE~ 
ALl. 2  GATATCG  CCAGCTGCTAT  AAAAGT 
nxp2 t  rRv~ 
ALl. 3  GATAAGGC  GTATTATGA  TACTCCAA 
TKI  GATCCGGTCCA  CAGCTGG  GCC 
AL3. i  GGATCGGGCGAAAACACCAAATGACTACGGTG  ACTACTTTC  CGACATAC 
AL3 .  2  CTATCCGCCG  ATAGTGGCTACGATT  CGGGGGAA 
AL3  4  GATCCGTCGCCT  TACAGTAAt  T  CAGTGGGTAGA 
~Ii  KEEl 
AL3.7  CGGATCCCGC  CAGCAGa  cGG  ACGATA  C 
AL3. 10  GATACCCGAGAGGAA  GATTTTTGGAGTGGTTATTATA 
AL3 .  I  I  GGCCCG  TATTTTGACTGGTTA  AGG 
AL3.16  TGTAGCGAACT  CGATATTTTGACTGGTcAgT 
GCTTTTGATTC  TGGGG 
TACTgCGcTATGGACGTC  TGGGG 
TTGACTAC  TGGGG 
AACTGGTTCGACcCC  TGGGG 
TACTTTGACTAC  TGGGG 
TACTTTGACTAC  TGGGG 
TTTGACTAC  TGGGG 
TACTTTGACTAC  TGGGG 
ACTACTACGGTATGGACGTC  TGGGG 
TGACTAC  TGGGG 
B 
i  Framework  I 
2  4  5  6  8  9  12  1516 
q  S  V  L  T  q  S  F  S  V  S  A  A  P  G  q  K  V  T  I 
2F7  cagtctgtgttgacgcagtcgccctcagtgtctgcggccecaggacagaaggtcaccatc  60 
I  ..................  e  ......................................... 
2  ..................  C  ......................................... 
3  ...........................................................  C 
4  C  a  .... 
5  ..................  C  ......................................... 
CDR  I  ,  r 
~r  25  33  36 
SCSGSTSNIGNNFVSWYQQL 
2F7  tcctgctctggaagcacctccaacattggcaataattttgtatcctggtaccagcaaetc  120 
1  ................  g  ............  g  .......  a  ..................  g--- 
2  ........  c ....  c--g ............  g ....... a ............  t  ..... g--- 
3  ................  g  ............  g ....... a ..................  g--- 
4  ................  g ...........  cg  ....... a ..................  g--- 
5  ................  g ............  g---g---a  ...............  a--gg-- 
--Framework  II  71  CDR  II  ir 
40  41  44  46  47  56  57 
PGTAPKLLIYGNDKRPSGIP 
2F7  ccaggaacagcccccaaactectcatttatggcaatgataagegaccc~cagggattect  180 
1  ...............................  a ....  a ....................... 
2  ...............................  a ....  a ....................... 
3  ...............................  a ....  a ....................... 
4  .................  c ....  aa  ....  t  ...............  a ...... 
5  ...............................  a ....  a ....  a .................. 
Framework  III 
61  63  65  68  70  73  75  77  78 
DRFSGSKSGTSATLAITGLQ 
2F7  gaecgattctctggetccaagtctggcacgtcagceaecetggccatcaecggactccag  240 
I  ...........................................  g ................ 
2  ...........................................  g ..............  g- 
3  ...........................................  g ................ 
4  ...........................................  g ................ 
5  ...........................................  g ................ 
Ir  CDR  III  i 
83  86  88  95  a  b  96  97 
TGDEADYYCVTWDSSLHNVL 
2F7  actggggacgaggccgattattactgcgtaacatgggatagcagcctgcataatgtctta  300 
1  ............................  g ...................  ag-gc--ggg-- 
2  ............................  c  ...................  ag-ge---gg-g 
3  ............................  g ...................  ag-geet-gg-g 
4  ..... t  ...........  g ..........  g ...................  ag-gg---gga- 
5  ............................  g ....... a---a ....... ag-gg-tggg-g 
Framework  IV 
198  106  a  167 
LGGGTKLTVLG 
2F7  ttgggcggagggaccaagctgaccgtcctgggt  333 
i  --C  ..........................  a--- 
2  --c  ..........................  aa-- 
3  --c--a ..... c---c .............  c--- 
4  -  -c  ..........................  a-  -  - 
5  --c  ........  a  .................  a--- 
Figure  5.  Nudeotide sequences 
of the CDK3 segments of the 12 
V.18/2 hybridizing plaques. Areas 
with identity to known germline 
gene segments  are shown in bold 
type, mutations in plain type. These 
sequence  data are  available from 
EMBL/GenBank/DDBJ under ac- 
cession numbers X67060-X67074. 
413  Stewart et al. Table  2.  Frequency of Oligonucleotide Hybridization to VH3 
DNA  Libraries  from a Normal Adult (AKS),  a Tonsil (FAR), 
and from  Two Patients with Active SLE and High-Titer 
Anti-DNA  Antibodies 
Name  V.3  V.18/2  V.56P1 
%  % 
AKS  177  34 (19)  27 (15) 
VAR  79  22 (28)  12 (15) 
JAV  80  16 (20)  5 (6) 
LG  140  0  - 
to-silent ratio of 1.3. Although PCR error may also introduce 
mutation,  our previous work indicated that  no more than 
1 base in 300 is likely to be misincorporated  (15). 
In  7  of 11  sequenced V818/2  genes,  100%  identity  to 
known D  gene segments could be demonstrated over 9-22 
bases in length (Fig. 5). The D gene families DXP (five clones) 
and DLR (three clones) accounted for 8 of the 11 sequenced 
clones, a finding that reflects the overrepresentation of these 
gene families in normal subjects (15-17).  The J.4 gene is also 
overrepresented in the normal repertoire (15-17) and was used 
by 7 of the  11 V.18/2  clones described here. 
V,,18/2  Is  Found  at  High  Frequency  in  VH3-specific 
Libraries.  In addition to the three C# libraries just discussed, 
VH3-specific libraries  were generated  from the lymphocyte 
DNA of one adult (AKS) and from a tonsillectomy sample 
(VAR). As seen in Table 2, 19 and 28% of all V.3 + plaques 
in the two libraries  hybridized to the Va18/2 CDR2 probe. 
The V.56P1 probe hybridized to  15%  of the V.3 plaques 
in each library.  Randomly sequenced plaques demonstrated 
that these libraries consisted of independent clones.  12 plaques 
picked at random from AKS were sequenced through CDR1 
(Table 3). 3 of the 12 shared 97.4, 99, and 99.6% sequence 
identity  with  V.18/2.  Three  (ks.5,  ks.6,  ks.17)  shared 
>98%  homology  with  a  V.3  family  member  (N54P3) 
found in  cord blood (18),  two clones (ks.9,  ks.19)  shared 
>97%  with  the fetal cDNA  clone M26,  and  1 of the  12 
(ks.16) had 98% identity with V.56pl.  10 of 12 rearranged 
VH genes found in adult B ceils  appear to derive from the 
so-called "fetal repertoire"  of V. genes. 
VH18/2 in SLE.  The V.18/2  heavy chain is the major 
determinant  of Id 16/6 (2). Levels of this Id fluctuate with 
disease activity in SLE and can be detected in the character- 
istic skin and renal lesions of this disease (19, 20). We there- 
fore predicted that, at least in some patients with active dis- 
ease, V.18/2 would be found at a frequency higher than that 
observed in normal adults. To test this hypothesis, DNA ex- 
tracted from the PBLs of two SLE patients with high-titer 
anti-DNA antibodies (LG and JAV) was PCR amplified with 
V.3-specific  primers,  and  packaged  in  M13  as  described 
above. Hybridization analysis revealed that in patient JAV 20% 
of V.3 clones hybridized to V.18/2,  and 6% of V.3 clones 
to V.56P1, numbers consistent with those found in normal 
individuals  (Table  2).  In  patient  LG,  however,  no V.18/2 
was detected on hybridization.  Indeed,  analysis  of this pa- 
tient's serum failed to detect any Id 16/6. Granulocyte DNA 
from patient  LG was amplified with  a V.3 Fr3 and a Va3 
leader primer. A Southern transfer of the product hybridized 
at high stringency to the V.18/2 5' CDR.2 probe, a finding 
that implies that this patient has a germline copy of V.18/2 
that  does not  appear in the peripheral  B cell population. 
V,18/2  in IgG-specific Libraries.  As the pathogenic  au- 
toantibodies in SLE are high-titer,  high-affinity  IgG antibodies, 
Table  3.  Results of Sequence Analysis of Randomly Picked VH3 DNA  Clones from a Normal Adult (AKS) 
Clone  Homology  Gene bank  VH bases sequenced  D.  J, 
% 
KS. 1  99  V826  283  DN4  4 
KS.3  97.4  VH26  228  DN1  1 
KS.4  99.6  VH26  252  DXP3  4 
KS.9  97.2  M26  253  DLR3  5 
KS.19  97.9  M26  283  -  - 
KS.16  99.6  FL2-2  279  DLR4  6 
KS.5  97.9  N54P3  274  DXP3  4 
KS.6  99.6  N54P3  227  -  6 
KS. 17  98.9  N54P3  282  -  4 
KS. 10  94.5  V-GL616  249  -  4 
KS.20  89.2  63P1  213  DXP'I  6 
KS.4  87.3  V.26  252  DN1  4 
KS.16 is 98.6% homologous to V,56P1. 
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Figure  6.  The frequency of V818/2  as a percentage  of V.3 in the Ig 
libraries. The number of V.3 + plaques studied is shown above each bar. 
A/~ and A#2 libraries were prepared  from the same subject,  1 yr apart. 
we were interested in the frequency of use and mutation of 
V.18/2 in the IgG populations of normal donors. An IgG- 
specific cDNA library was amplified to include all V. fami- 
lies (A3'). Hybridization results from this library revealed 45 
V.18/2 § plaques  (7% of V.3 and 4%  of all J.)  (Table 1). 
Four V.18/2 hybridizing plaques were sequenced and were 
identical in CDR3. As this may invalidate the hybridization 
data, randomly picked J.+  plaques were also sequenced.  3 
of 30 randomly picked plaques with independent CDR3 seg- 
ments were 96, 99,  and 100%  homologous to V.18/2 at 
least through CDR1 (not shown). The frequency of V.18/2 
expression,  as determined by random sequencing, is there- 
fore at least  7%  of JH in this Cy library. 
Discussion 
Although 100-200 bands can be seen on Southern blot 
analysis of human DNA hybridized with V. family-specific 
probes, the exact number of functional VH genes available for 
rearrangement is unknown (21). The finding of recurrent in- 
dividual V. genes in B cell malignancies (22), fetal liver B 
cells (11, 23), and in autoantibodies produced by adults (24) 
suggests that some individual V. gene segments are prone 
to preferential  selection, or alternatively  that the number of 
VH genes available for use in mature V.DJ recombinations 
may be lower than expected (25). 
The germline gene V.18/2 is a member of the largest V~ 
family (VH3) and is identical to V.26, which was originally 
identified on the basis of its homology to a murine V. gene 
probe (26). Subsequently, V.26 has been identified with sur- 
prising frequency in fetal liver B cells (10, 21), anti-DNA 
and other autoantibodies (27, 28), B cell malignancies (29), 
and in the antibody response of normal individuals to im- 
munization with hemophilus B (30, 31). However, since the 
representation of V.18/2 in the repertoire of normal B cells 
was hitherto unknown, interpretation of the overrepresenta- 
tion of this gene in pathologic conditions was difficult. 
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The V.18/2 gene segment is demonstrated here to be 
overrepresented in the unstimulated peripheral blood B cells 
of normal individuals, with 4-10%  of all J.+  plaques and 
12-33%  of all  V.3 +  plaques  hybridizing  to  a  V.18/2- 
specific probe (Fig. 6). Thus, although the V.3 family is es- 
timated to contain at least 25 members, a single VH gene ac- 
counts for up to 25% of all expressed members of this family. 
Moreover, this value of 25% is likely to be an underestimate 
of the true frequency of V.18/2 because the high-stringency 
conditions used to identify the gene would miss mutant vari- 
ants in CDR2. The frequency of rearrangement of another 
recurring V.3 family member, studied for comparative pur- 
poses (V.56pl), was 2% ofJ. § and 6-15% of VH3 + plaques. 
As a further comparison, V.21/28, a member of the large 
V.1 family, also represented 2% of all J.+  plaques  (6-7% 
of all V.1 plaques).  Thus, although V.18/2 predominates, 
all of the studied V. genes are rearranged at a higher than 
expected frequency, assuming a total of at least 100 functional 
V. genes. 
Examples of other V gene sequences identified at high fre- 
quency  in  normal  individuals  include  the  V.4  family 
member V.4.21 (31), the V.1 family member V.51pl (32) 
the VK gene humkv.3.25 (33, 34), the D gene segment Dnl 
(15-17),  and the J. gene J.4  (15-17).  V.51pl and Vh4.21 
have been identified by their respective idiotypic markers in 
2 and 3% of tonsillar B cells, and V.4.21 in 10%  of bone 
marrow B cells (31, 32). V.6 and the recently described V.7 
gene segment have been found at high frequency in fetal (11, 
23) and cord blood B cells (18), and in up to 6% of all cir- 
culating B cells in one normal adult (15). It is likely that 
other  examples  of V.  genes found at  high frequency in 
normal individuals remain to be identified. By extension, it 
is therefore possible that the expressed repertoire of human 
V genes will ultimately prove to represent only a fraction 
of the potentially available germline. 
A  number of reasons  have been proposed for the over- 
representation of certain germline V genes in fetal liver, au- 
toantibodies, B cell malignancy, and now in normal individ- 
uals. These relate to chromosomal position (35), the number 
of gene copies in the germline (36), preferential  rearrange- 
ment on the grounds of unique recombinase accessibility or 
recognition sequences, the presence of gene-specific promotor 
enhancer sequences (37), and preferential selection on the basis 
of antigen binding or Id specificities (38). 
A gene product may be found at higher than predicted 
frequency if more than one copy exists in the germline. In 
fact, there are probably two copies of V.18/2 in the germ- 
line (5), and this may partially explain its preponderance in 
the repertoire.  However, as our V.56pl probe recognizes at 
least two highly related yet independent germline V. genes 
(13, 14), the predominance of V.18/2  over V.56p1  (and 
related genes) in this study implicates factors other than mul- 
tiple copies. 
V.18/2 is highly conserved and its coding region is not 
polymorphic (5). This suggests that V.18/2 may be prefer- 
entially selected because of the antigen binding or idiotypic 
properties of its protein product. V.18/2 has a sequence in 
Fr3 that is highly conserved between species and within the V.3 family,  but that  differs  from other families (37).  This 
sequence may encode a unique antigen binding  site in the 
protein  product  not  related  to  the  classical  CDR-related 
binding  sites.  Of interest,  the consensus sequence from all 
known V.3 family members is identical to the V.18/2  se- 
quence in  this region.  It is therefore  notable that  9  of 11 
V.18/2  amino acid substitutions found in this study were 
in  Fr3  (Figs.  4  and  5).  Perhaps V,18/2  is selected on the 
basis of this highly conserved potential antigen binding site. 
Precedence for this hypothesis has been demonstrated in mice 
in which clonal persistence orB lyrnphocytes in normal animals 
is determined  by V. family-dependent  selection (39). 
Since Id16/6 is abundant  in the serum of some patients 
with active SLE and its levels fluctuate with disease activity, 
we expected to find an excess of V.18/2 plaques in some pa- 
tients  with  active SLE.  In  a VH3 family library  amplified 
from the DNA of a patient (JAV) with active lupus, V.18/2 
was found to be rearranged  in 20%  of V.3 + clones, a fre- 
quency similar to that of normal individuals. In a second pa- 
tient (LG), a patient without detectable Id in the serum, no 
V.18/2  was identified by hybridization.  By PCR analysis 
this patient appears to have a copy of V.18/2 in the germ- 
line,  and the absence of rearranged  VH18/2 in this patient 
remains  unexplained. 
It therefore appears, at least from these limited studies,  that 
a difference in the frequency of use of V.18/2 cannot explain 
the elevated levels of Id 16/6 in patients  with  active SLE. 
Our observation could be explained if other V. genes con- 
tribute to the Id (2), if activation of normally quiescent B 
cells bearing an 18/2 rearrangement  results in the release of 
the Id into the serum,  or if plasma cells producing Id 16/6 
are sequestered from the circulation. 
A possibility not previously considered is that the number 
of germline  V.  genes used in  rearrangements  is far lower 
than supposed. Such a limitation in diversity has been demon- 
strated in other species, such as the chicken and rabbit, which 
both generate diversity using an extremely restricted set of 
V. genes (40, 41).  The chicken uses only one VH and one 
VX gene. Indeed, all other VX genes in the germline of the 
species are pseudogenes, portions of which are subsequently 
used in gene conversion events to generate antibody diver- 
sity.  In the rabbit,  only one of many functional V.  genes 
is used.  This  gene  (V.1),  which  is  the  most  3'  V.  gene, 
generates  diversity by a combination  of somatic mutation 
and gene conversion. While gene conversion events are prob- 
able in  humans  their  presence  has  yet  to  be conclusively 
documented (16). 
The  majority  of the  C#  VH18/2  clones  we  sequenced 
showed little mutation,  even in CDR3, suggesting that the 
population of IgM + B cells bearing VH18/2 rearrangements 
may form part of the naive immune repertoire.  Unmutated 
VH18/2 was also found in a C3' library.  Taken together with 
the demonstration that V.18/2 can encode the heavy chains 
of anti-DNA antibodies, this finding suggests that germline 
genes capable of forming naturally occurring autoantibodies 
are not deleted from the IgG population of B cells in normal 
individuals. 
Our results suggest that a significant  fraction of the human 
Ig repertoire originates from a preimmune repertoire that is 
dominated by relatively few V genes. In this regard the remark- 
able polyspecifidty of antibodies encoded by germline V genes 
may be important.  A limited number of polyreactive clones 
could form the substrate from which a diverse repertoire arises 
after clonal selection (24). 
The recurrent  presence of individual  germline VH genes 
can now be extended from the restricted B cell populations 
of the fetal repertoire,  autoantibodies,  and B cell malignan- 
cies to the expressed V gene repertoire of normal adults. We 
postulate that only a fraction of available germline V genes 
are used recurrently in the expressed repertoire, and that poly- 
specificity of naturally occurring antibodies in combination 
with CDR3 and somatic mutation compensate for the re- 
striction  to antibody diversity.  The mechanisms by which 
preferential  use  of  an  individual  V.  gene  arise  remain 
speculative and deserve further  investigation. 
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